These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 20642748)

  • 1. Relationship between clinical characteristics of narcolepsy and CSF orexin-A levels.
    Nakamura M; Kanbayashi T; Sugiura T; Inoue Y
    J Sleep Res; 2011 Mar; 20(1 Pt 1):45-9. PubMed ID: 20642748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
    Nishino S; Kanbayashi T
    Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple sleep latency measures in narcolepsy and behaviourally induced insufficient sleep syndrome.
    Marti I; Valko PO; Khatami R; Bassetti CL; Baumann CR
    Sleep Med; 2009 Dec; 10(10):1146-50. PubMed ID: 19464232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypocretin deficiency in narcolepsy with cataplexy is associated with a normal body core temperature modulation.
    Grimaldi D; Agati P; Pierangeli G; Franceschini C; Guaraldi P; Barletta G; Vandi S; Cevoli S; Plazzi G; Montagna P; Cortelli P
    Chronobiol Int; 2010 Sep; 27(8):1596-608. PubMed ID: 20854137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Narcolepsy without cataplexy: 2 subtypes based on CSF hypocretin-1/orexin-A findings.
    Oka Y; Inoue Y; Kanbayashi T; Kuroda K; Miyamoto M; Miyamoto T; Ikeda A; Shimizu T; Hishikawa Y; Shibasaki H
    Sleep; 2006 Nov; 29(11):1439-43. PubMed ID: 17162990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy.
    Andlauer O; Moore H; Hong SC; Dauvilliers Y; Kanbayashi T; Nishino S; Han F; Silber MH; Rico T; Einen M; Kornum BR; Jennum P; Knudsen S; Nevsimalova S; Poli F; Plazzi G; Mignot E
    Sleep; 2012 Sep; 35(9):1247-55F. PubMed ID: 22942503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Undetectable levels of CSF hypocretin-1 (orexin-A) in two prepubertal boys with narcolepsy.
    Tsukamoto H; Ishikawa T; Fujii Y; Fukumizu M; Sugai K; Kanbayashi T
    Neuropediatrics; 2002 Feb; 33(1):51-2. PubMed ID: 11930279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanin concentrating hormone in central hypersomnia.
    Peyron C; Valentin F; Bayard S; Hanriot L; Bedetti C; Rousset B; Luppi PH; Dauvilliers Y
    Sleep Med; 2011 Sep; 12(8):768-72. PubMed ID: 21697009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of clinical characteristics among narcolepsy with and without cataplexy and idiopathic hypersomnia without long sleep time, focusing on HLA-DRB1( *)1501/DQB1( *)0602 finding.
    Sasai T; Inoue Y; Komada Y; Sugiura T; Matsushima E
    Sleep Med; 2009 Oct; 10(9):961-6. PubMed ID: 19410508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypocretin (orexin) deficiency predicts severe objective excessive daytime sleepiness in narcolepsy with cataplexy.
    Baumann CR; Khatami R; Werth E; Bassetti CL
    J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):402-4. PubMed ID: 16484654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency.
    Knudsen S; Gammeltoft S; Jennum PJ
    Brain; 2010 Feb; 133(Pt 2):568-79. PubMed ID: 20129934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypocretin/orexin and sleep: implications for the pathophysiology and diagnosis of narcolepsy.
    Overeem S; Scammell TE; Lammers GJ
    Curr Opin Neurol; 2002 Dec; 15(6):739-45. PubMed ID: 12447114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective REM sleep deprivation in narcolepsy.
    Vu MH; Hurni C; Mathis J; Roth C; Bassetti CL
    J Sleep Res; 2011 Mar; 20(1 Pt 1):50-6. PubMed ID: 20880101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlates of sleep-onset REM periods during the Multiple Sleep Latency Test in community adults.
    Mignot E; Lin L; Finn L; Lopes C; Pluff K; Sundstrom ML; Young T
    Brain; 2006 Jun; 129(Pt 6):1609-23. PubMed ID: 16597649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A).
    Bassetti C; Gugger M; Bischof M; Mathis J; Sturzenegger C; Werth E; Radanov B; Ripley B; Nishino S; Mignot E
    Sleep Med; 2003 Jan; 4(1):7-12. PubMed ID: 14592354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Narcolepsy and the hypocretins.
    Wurtman RJ
    Metabolism; 2006 Oct; 55(10 Suppl 2):S36-9. PubMed ID: 16979425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Narcolepsy--new implications of molecular biology].
    Knudsen S; Jennum PJ
    Ugeskr Laeger; 2006 Oct; 168(43):3699-704. PubMed ID: 17069732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical spectrum of narcolepsy with cataplexy: a reappraisal.
    Sturzenegger C; Bassetti CL
    J Sleep Res; 2004 Dec; 13(4):395-406. PubMed ID: 15560774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of narcolepsy in Norwegian children and adolescents after vaccination against H1N1 influenza A.
    Heier MS; Gautvik KM; Wannag E; Bronder KH; Midtlyng E; Kamaleri Y; Storsaeter J
    Sleep Med; 2013 Sep; 14(9):867-71. PubMed ID: 23773727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features of childhood narcolepsy. Can cataplexy be foretold?
    Nevsimalova S; Jara C; Prihodova I; Kemlink D; Sonka K; Skibova J
    Eur J Paediatr Neurol; 2011 Jul; 15(4):320-5. PubMed ID: 21345702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.